Skip navigation

DAY ONE WEDNESDAY, SEPTEMBER 27, 2017

7:45

Conference Registration and Breakfast

8:45

Chairman’s Welcome and Opening Remarks

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Strategies to Scale the Business in a
High-Growth Life Science Company

9:10

OPENING KEYNOTE PANEL Leading in Finance and Creating Value —
The Art and Science of the CFO in Today’s Cutting-Edge Biotech Company

MODERATOR:

Bill Kracunas
National Leader, Management Consulting
RSM US LLP

PANELISTS:

Federica “Freddi” O’Brien
Chief Financial Officer
Complexa, Inc.

Chip Baird
Chief Financial Officer
Amicus Therapeutics

Mark Guerin
Chief Financial Officer
Onconova Therapeutics, Inc.

10:10

Networking and Refreshment Break

Key Updates, Practical Guidance and
Technical Accounting Hot Topics

10:40/p>

Implications of the New Revenue Recognition Standard on Financial Reporting, Processes and Disclosures

Matt Coffland
Partner
RSM US LLP

11:25

SEC Hot Topics and SEC Comment Letters

Ryan Dolan
Managing Director
CFGI

12:15

Networking Luncheon

1:30

INDUSTRY PANEL — TECHNICAL ACCOUNTING UPDATES Key Issues and Practical Considerations for Accounting and Controllership within the Life Sciences Arena — A Review of Hot Topics

I. Leases — Update on the New Leases Standard and Practical Approaches to Implement Changes

II. Revenue Recognition — New Guidance and Experiences Implementing Key Changes

III. Collaborations Disclosure and Accounting Considerations

IV. Controllership — The Evolving and Expanding Role of the Corporate Controller within Life Science Companies

MODERATOR:

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services & Policy
Johnson & Johnson

PANELIST:

Jason Pitofsky
Executive Director, Financial Reporting
Regeneron Pharmaceuticals

Kelly MacDonald
Director, Commercial Finance and Technical Accounting
Ironwood Pharmaceuticals

Financial Systems and Processes that
Pave the Path for Growth

2:30

CASE STUDY Roadmap Through Commercialization —
How One Innovative Life Science Company Paved the Path for Growth

Ana Bowman
Controller
Omeros Corporation

3:15

Networking and Refreshment Break

3:45

Venture Capital, ‘Term Sheets’ and a Road Map of the Material Terms of a Transaction

Ryan J. Udell
Partner and Co-Chair, Corporate Securities Practice
White and Williams LLP

4:30

IPO PANEL IPO Watch-Outs and Insights for Transitioning, Commercializing and Scaling the Business

MODERATOR:

Jim Quinlan
Partner
CFGI

PANELISTS:

Jonathan Freve
Chief Financial Officer
Spring Bank Pharmaceuticals, Inc.

John Green
Corporate Controller, Principal Accounting Officer and Treasurer
Merrimack Pharmaceuticals

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, SEPTEMBER 28, 2017

7:30

Continental Breakfast

8:00

Chairman’s Review of Day One

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Commercialization Strategies and
Business Models for New Product Success

8:45

DAY TWO OPENING ADDRESS Product Commercialization Strategies — Distribution Models and Contracting with Partners for New Launch Success

William Roberts
Partner
Ernst & Young LLP

Richard Capasso
Executive Director
Ernst & Young LLP

9:30

Strategies for Effectively Working with Third-Parties

Rick Shriner
Principal
RSM US LLP

Nancy Aubrey
Partner
RSM US LLP

10:15

Networking and Refreshment Break

Building and Leading a Best-In-Class Financial Organization within a High-Growth Bioscience Company

10:45

Talent, Team Leadership, Cross-Functional Excellence and Organizational Design

MODERATOR:

Brian Filippini
President
Concord Management Group Int'l

PANELISTS:

Gina Consylman
Vice President of Finance and Chief Accounting Officer
Ironwood Pharmaceuticals

Thomas P. Hess
Senior Vice President and Chief Financial Officer
Genomind

John C. Deighan
Chief Financial Officer
Exeltis USA

Rhonda Chicko
Vice President, Finance
Editas Medicine

11:30

Setting the Pace and Steering the Course for Growth — Strategies for a Sustainable Finance Function that Scales with the Business

Peter Licata
Chief Financial Officer
Edenbridge Pharmaceuticals

Dave Lewin
Managing Director, Accounting Advisory Practice
CBIZ Tofias

12:15

Networking Luncheon

Financing Models and Considerations
for Raising Capital

1:30

CASE STUDY IPOs and Reverse Mergers —
Pearls of Wisdom from Executing Various Transactions

Dave Lowrance
Chief Financial Officer
Savara

2:15

Close of Conference

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, SEPTEMBER 27, 2017

7:45

Conference Registration and Breakfast

8:45

Chairman’s Welcome and Opening Remarks

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Strategies to Scale the Business in a
High-Growth Life Science Company

9:10

OPENING KEYNOTE PANEL Leading in Finance and Creating Value —
The Art and Science of the CFO in Today’s Cutting-Edge Biotech Company

MODERATOR:

Bill Kracunas
National Leader, Management Consulting
RSM US LLP

PANELISTS:

Federica “Freddi” O’Brien
Chief Financial Officer
Complexa, Inc.

Chip Baird
Chief Financial Officer
Amicus Therapeutics

Mark Guerin
Chief Financial Officer
Onconova Therapeutics, Inc.

10:10

Networking and Refreshment Break

Key Updates, Practical Guidance and
Technical Accounting Hot Topics

10:40/p>

Implications of the New Revenue Recognition Standard on Financial Reporting, Processes and Disclosures

Matt Coffland
Partner
RSM US LLP

11:25

SEC Hot Topics and SEC Comment Letters

Ryan Dolan
Managing Director
CFGI

12:15

Networking Luncheon

1:30

INDUSTRY PANEL — TECHNICAL ACCOUNTING UPDATES Key Issues and Practical Considerations for Accounting and Controllership within the Life Sciences Arena — A Review of Hot Topics

I. Leases — Update on the New Leases Standard and Practical Approaches to Implement Changes

II. Revenue Recognition — New Guidance and Experiences Implementing Key Changes

III. Collaborations Disclosure and Accounting Considerations

IV. Controllership — The Evolving and Expanding Role of the Corporate Controller within Life Science Companies

MODERATOR:

Stephen Rivera
Vice President, Global Technical Accounting Advisory Services & Policy
Johnson & Johnson

PANELIST:

Jason Pitofsky
Executive Director, Financial Reporting
Regeneron Pharmaceuticals

Kelly MacDonald
Director, Commercial Finance and Technical Accounting
Ironwood Pharmaceuticals

Financial Systems and Processes that
Pave the Path for Growth

2:30

CASE STUDY Roadmap Through Commercialization —
How One Innovative Life Science Company Paved the Path for Growth

Ana Bowman
Controller
Omeros Corporation

3:15

Networking and Refreshment Break

3:45

Venture Capital, ‘Term Sheets’ and a Road Map of the Material Terms of a Transaction

Ryan J. Udell
Partner and Co-Chair, Corporate Securities Practice
White and Williams LLP

4:30

IPO PANEL IPO Watch-Outs and Insights for Transitioning, Commercializing and Scaling the Business

MODERATOR:

Jim Quinlan
Partner
CFGI

PANELISTS:

Jonathan Freve
Chief Financial Officer
Spring Bank Pharmaceuticals, Inc.

John Green
Corporate Controller, Principal Accounting Officer and Treasurer
Merrimack Pharmaceuticals

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, SEPTEMBER 28, 2017

7:30

Continental Breakfast

8:00

Chairman’s Review of Day One

John Lanza
National Life Sciences Industry Leader
RSM US LLP

Commercialization Strategies and
Business Models for New Product Success

8:45

DAY TWO OPENING ADDRESS Product Commercialization Strategies — Distribution Models and Contracting with Partners for New Launch Success

William Roberts
Partner
Ernst & Young LLP

Richard Capasso
Executive Director
Ernst & Young LLP

9:30

Strategies for Effectively Working with Third-Parties

Rick Shriner
Principal
RSM US LLP

Nancy Aubrey
Partner
RSM US LLP

10:15

Networking and Refreshment Break

Building and Leading a Best-In-Class Financial Organization within a High-Growth Bioscience Company

10:45

Talent, Team Leadership, Cross-Functional Excellence and Organizational Design

MODERATOR:

Brian Filippini
President
Concord Management Group Int'l

PANELISTS:

Gina Consylman
Vice President of Finance and Chief Accounting Officer
Ironwood Pharmaceuticals

Thomas P. Hess
Senior Vice President and Chief Financial Officer
Genomind

John C. Deighan
Chief Financial Officer
Exeltis USA

Rhonda Chicko
Vice President, Finance
Editas Medicine

11:30

Setting the Pace and Steering the Course for Growth — Strategies for a Sustainable Finance Function that Scales with the Business

Peter Licata
Chief Financial Officer
Edenbridge Pharmaceuticals

Dave Lewin
Managing Director, Accounting Advisory Practice
CBIZ Tofias

12:15

Networking Luncheon

Financing Models and Considerations
for Raising Capital

1:30

CASE STUDY IPOs and Reverse Mergers —
Pearls of Wisdom from Executing Various Transactions

Dave Lowrance
Chief Financial Officer
Savara

2:15

Close of Conference